Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Hemispherx Biopharma Inc (NYSE American:HEB)

0.3658
Delayed Data
As of 6:29pm ET
 -0.0342 / -8.55%
Today’s Change
0.30
Today|||52-Week Range
2.64
-46.97%
Year-to-Date
No recent news for Hemispherx Biopharma Inc.

Today’s Trading

Previous close0.40
Today’s open0.40
Day’s range0.36 - 0.41
Volume148,315
Average volume (3 months)298,972
Market cap$11.7M
Dividend yield--
Data as of 6:29pm ET, 08/21/2017

Growth & Valuation

Earnings growth (last year)+52.78%
Earnings growth (this year)--
Earnings growth (next 5 years)+35.00%
Revenue growth (last year)-30.83%
P/E ratioNM
Price/Sales163.59
Price/Book0.62

Competitors

 Today’s
change
Today’s
% change
SBOTStellar Biotechnolog...+0.03+2.61%
RPRXRepros Therapeutics ...-0.01-4.13%
ARGSArgos Therapeutics I...+0.00+0.21%
EVARLombard Medical Inc+0.00+0.29%
Data as of 4:00pm ET, 08/21/2017

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$92.0K
Annual profit (last year)-$7.5M
Net profit margin-8,154.35%

Profile

Sector
Health Technology
Industry
Biotechnology
Executive Vice Chairman, President &
CEO
Thomas Kenwood Equels
Senior Vice President-
Operations
Wayne S. Springate
Corporate headquarters
Philadelphia, Pennsylvania

Forecasts